Advertisement
Screener

NASDAQ:SXTP | Development Costs, Period Cost | 60 DEGREES PHARMACEUTICALS, INC.

0.6 / 5 stars · 14/120 Roast Me

60 DEGREES PHARMACEUTICALS, INC. Development Costs, Period Cost

Discontinued › Expense Statement › Operating Expenses

us-gaap:DevelopmentCosts · last filed 2024-05-15

  • 60 DEGREES PHARMACEUTICALS, INC. development costs, period cost for the quarter ending 2024-03-31 was $9.09K, a 73.19% decline year-over-year.
  • 60 DEGREES PHARMACEUTICALS, INC. development costs, period cost for the quarter ending 2023-09-30 was $12.28K.
  • 60 DEGREES PHARMACEUTICALS, INC. development costs, period cost for the quarter ending 2023-06-30 was $0.00.
  • 60 DEGREES PHARMACEUTICALS, INC. development costs, period cost for the quarter ending 2023-03-31 was $33.90K.
Period endDevelopment Costs, Period Cost 3 monthDevelopment Costs, Period Cost 6 monthDevelopment Costs, Period Cost 9 month
2024-03-31$9.09K
10-Q · filed 2024-05-15
2023-09-30$12.28K
10-Q · filed 2023-11-20
$12.28K
derived: sum of 2 quarters · filed 2023-11-20
$52.18K
10-Q · filed 2023-11-20
2023-06-30$0.00
10-Q · filed 2023-08-25
$0.00
10-Q · filed 2023-08-25
2023-03-31$33.90K
10-Q · filed 2024-05-15
2022-09-30$0.00
10-Q · filed 2023-11-20
$0.00
10-Q · filed 2023-11-20